233 related articles for article (PubMed ID: 17449328)
21. Granulocyte/macrophage colony-stimulating factor and interleukin-4-induced dendritic cells.
Hikino H; Kasono K; Kanzaki M; Kai T; Konishi F; Kawakami M
Anticancer Res; 2004; 24(3a):1609-15. PubMed ID: 15274330
[TBL] [Abstract][Full Text] [Related]
22. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
Ji YB; Zhou JH; Zuo MX; You QD
Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773
[TBL] [Abstract][Full Text] [Related]
23. Non-transmissible Sendai virus encoding granulocyte macrophage colony-stimulating factor is a novel and potent vector system for producing autologous tumor vaccines.
Inoue H; Iga M; Nabeta H; Yokoo T; Suehiro Y; Okano S; Inoue M; Kinoh H; Katagiri T; Takayama K; Yonemitsu Y; Hasegawa M; Nakamura Y; Nakanishi Y; Tani K
Cancer Sci; 2008 Nov; 99(11):2315-26. PubMed ID: 18957055
[TBL] [Abstract][Full Text] [Related]
24. Increased survival and decreased tumor size due to intratumoral injection of ethanol followed by administration of immature dendritic cells.
Kumagi T; Akbar SM; Horiike N; Onji M
Int J Oncol; 2003 Oct; 23(4):949-55. PubMed ID: 12963973
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
Kumano M; Hara I; Furukawa J; Oniki S; Nagai H; Miyake H; Fujisawa M
J Urol; 2007 Oct; 178(4 Pt 1):1504-9. PubMed ID: 17707061
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of antitumor activity of CD40L, RANKL, and 4-1BBL in vivo following intratumoral administration of viral vectors or transduced dendritic cells.
Yurkovetsky ZR; Shurin GV; Barry DA; Schuh AC; Shurin MR; Robbins PD
J Gene Med; 2006 Feb; 8(2):129-37. PubMed ID: 16288496
[TBL] [Abstract][Full Text] [Related]
27. Development of an effective method for dendritic cell immunotherapy of mouse melanoma.
Lee TH; Cho HK; Cho YH; Lee MG
Scand J Immunol; 2009 Aug; 70(2):85-92. PubMed ID: 19630913
[TBL] [Abstract][Full Text] [Related]
28. Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells.
Hu J; Yuan X; Belladonna ML; Ong JM; Wachsmann-Hogiu S; Farkas DL; Black KL; Yu JS
Cancer Res; 2006 Sep; 66(17):8887-96. PubMed ID: 16951206
[TBL] [Abstract][Full Text] [Related]
29. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
Hahm ER; Arlotti JA; Marynowski SW; Singh SV
Clin Cancer Res; 2008 Feb; 14(4):1248-57. PubMed ID: 18281560
[TBL] [Abstract][Full Text] [Related]
30. Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors.
Li B; VanRoey M; Wang C; Chen TH; Korman A; Jooss K
Clin Cancer Res; 2009 Mar; 15(5):1623-34. PubMed ID: 19208793
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic immune response induced by intratumoral expression of the fusogenic membrane protein of vesicular stomatitis virus and cytokines encoded by adenoviral vectors.
Hoffmann D; Bayer W; Wildner O
Int J Mol Med; 2007 Nov; 20(5):673-81. PubMed ID: 17912460
[TBL] [Abstract][Full Text] [Related]
32. Gene transfer of CD40-ligand to dendritic cells stimulates interferon-gamma production to induce growth arrest and apoptosis of tumor cells.
Tomihara K; Kato K; Masuta Y; Nakamura K; Uchida H; Sasaki K; Tanaka T; Huang J; Hiratsuka H; Hamada H
Gene Ther; 2008 Feb; 15(3):203-13. PubMed ID: 17989706
[TBL] [Abstract][Full Text] [Related]
33. Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17.
Fransen JH; Hilbrands LB; Ruben J; Stoffels M; Adema GJ; van der Vlag J; Berden JH
Arthritis Rheum; 2009 Aug; 60(8):2304-13. PubMed ID: 19644874
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-12 transduced dendritic cells induce regression of established murine neuroblastoma.
Shimizu T; Berhanu A; Redlinger RE; Watkins S; Lotze MT; Barksdale EM
J Pediatr Surg; 2001 Aug; 36(8):1285-92. PubMed ID: 11479878
[TBL] [Abstract][Full Text] [Related]
35. Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice.
Li P; Schwarz EM; O'Keefe RJ; Ma L; Looney RJ; Ritchlin CT; Boyce BF; Xing L
Arthritis Rheum; 2004 Jan; 50(1):265-76. PubMed ID: 14730625
[TBL] [Abstract][Full Text] [Related]
36. Immunostimulatory effects of CpG-ODN upon dendritic cell-based immunotherapy in a murine melanoma model.
Pilon-Thomas S; Li W; Briggs JJ; Djeu J; Mulé JJ; Riker AI
J Immunother; 2006; 29(4):381-7. PubMed ID: 16799333
[TBL] [Abstract][Full Text] [Related]
37. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
Miyahara R; Banerjee S; Kawano K; Efferson C; Tsuda N; Miyahara Y; Ioannides CG; Chada S; Ramesh R
Cancer Gene Ther; 2006 Aug; 13(8):753-61. PubMed ID: 16543916
[TBL] [Abstract][Full Text] [Related]
38. Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice.
Zeis M; Frenzke H; Schmitz N; Uharek L; Steinmann J
Bone Marrow Transplant; 2002 Feb; 29(3):213-21. PubMed ID: 11859393
[TBL] [Abstract][Full Text] [Related]
39. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity].
You J; Wang CL; Hao XS
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273
[TBL] [Abstract][Full Text] [Related]
40. Synergistic anti-tumor effect of combination radio- and immunotherapy by electro-gene therapy plus intra-tumor injection of dendritic cells.
Wang YS; Tsang YW; Chi CH; Chang CC; Chu RM; Chi KH
Cancer Lett; 2008 Aug; 266(2):275-85. PubMed ID: 18397820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
